Company Information
CIN
Status
Date of Incorporation
27 January 2000
State / ROC
Delhi / ROC Delhi
Industry
Sub Category
Non-govt company
Last Balance Sheet
Last Annual Meeting
Paid Up Capital
442,000
Authorised Capital
500,000
Past Directors
Patents
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
